Maryrose Deguzman
Family · Tucson, AZNPI 1750556916
Payments from drug & device makers
Across 48 payments — averaging $73.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$447
- AstraZeneca$382
- GSK$327
- Johnson & Johnson$283
- Boehringer Ingelheim$240
- Organogenesis Inc.$227
- plus $2K from 16 others
What the payments were for
- Food & beverage$3,532100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 6 | $447 |
| AstraZeneca | 4 | $382 |
| GSK | 3 | $327 |
| Johnson & Johnson | 3 | $283 |
| Boehringer Ingelheim | 2 | $240 |
| Organogenesis Inc. | 1 | $227 |
| Sanofi-aventis U.S. LLC | 3 | $226 |
| AbbVie | 2 | $225 |
| Novo Nordisk | 2 | $199 |
| Mimedx Group, Inc. | 3 | $161 |
| Amgen | 1 | $125 |
| Mylan Specialty L.p. | 1 | $125 |
| KCI USA, Inc. | 2 | $109 |
| Irhythm Technologies, Inc. | 4 | $98 |
| Averitas Pharma Inc. | 1 | $77 |
| Redhill Biopharma Inc. | 1 | $71 |
| Integra Lifesciences Corporation | 3 | $50 |
| GRT US Holding, Inc. | 1 | $45 |
| Emergent Biosolutions Inc. | 1 | $45 |
| Lilly USA, LLC | 2 | $30 |
| Smith+Nephew | 1 | $25 |
| Exact Sciences | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$271
- FASENRA$250
- TRELEGY ELLIPTA$244
- JARDIANCE$240
- Puraply Antimicrobial$227
- FreeStyle Libre$147
- Yupelri$125
- EVENITY$125
- VRAYLAR$125
- FreeStyle Libre 2$123
- BREZTRI$121
- RYBELSUS$117
- TOUJEO$103
How this compares
$3,532 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Warfarin Sodium | 69 | $1,256 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $917 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $756 |
| Atorvastatin Calcium | 56 | $523 |
| Levothyroxine Sodium | 41 | $455 |
| Losartan Potassium | 26 | $259 |
| Rosuvastatin Calcium | 16 | $170 |
| Montelukast Sodium | 14 | $164 |
| Amlodipine Besylate | 29 | $164 |
| Lisinopril | 39 | $125 |
| Doxycycline Hyclate | 15 | $100 |
| Potassium Chloride | 12 | $97 |
| Tamsulosin Hcl | 11 | $83 |
| Omeprazole | 14 | $80 |
| Simvastatin | 16 | $79 |
Paid to pharmacies, not to this prescriber.
Other family in Tucson
- Lindsay CarterTucson$108K
- Vicki McIntyreTucson$68K
- Amber KemnitzTucson$33K
- Joy BaynesTucson$30K
- Cynthia CarstenTucson$27K
- Sharon MorganTucson$22K
- Margaret SpencerTucson$19K
- Polina SamoylovaTucson$18K
- Stephanie Niemi-OlsonTucson$15K
- Cindy ChangTucson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.